AMEXFinancialsFinancial - MortgagesSnapshot 2026-10-23
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
A matching fiscal period and sufficient coverage are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Improve free cash flow yield from negative levels | A primary condition in INCOME OPPORTUNITY REALTY INVESTORS INC's published investment case. The stated target is free cash flow yield >= 0% next 4 quarters. | Broken | free cash flow yield remains below 0% next 4 quarters | Free cash flow yield: -0.47% As of 2026-10-23; trailing twelve months. The target timing and basis require a separate assessment. Market data as of Oct 23, 2026-0.47 percent · calculatedLast status assessment Oct 24, 2026Measurement sourceconsolidated · TTM valuation Period ending Oct 23, 2026 Source: mart.stock_valuation_daily. Reference: IOR:2026-10-23. Source status: canonical calculation. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Maintain positive net income and profit margins | A primary condition in INCOME OPPORTUNITY REALTY INVESTORS INC's published investment case. The stated target is net income remains positive over next 4 quarters. | Intact | net income turns negative in any quarter | Net income: $705,000 FY2026-Q2; GAAP. Published target: net income remains positive over next 4 quarters. Target period is not explicitly aligned with this observation. Source published Aug 6, 2026705,000 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 8fa54917-3ce8-402e-b657-5a257a333cec. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Maintain valuation premium justified by fundamentals | Its price-to-earnings ratio is 18.8, higher than peers at 12.8, showing some premium. | Intact | P/E falls below peer median 12.8 | P/E (TTM): 19.37x As of 2026-10-23; trailing twelve months. The target timing and basis require a separate assessment. Market data as of Oct 23, 202619.3747 ratio · calculatedLast status assessment Oct 24, 2026Measurement sourceconsolidated · TTM valuation Period ending Oct 23, 2026 Source: mart.stock_valuation_daily. Reference: IOR:2026-10-23. Source status: canonical calculation. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Sep 25–Oct 24 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 5, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
IOR is a small financial business with a fragile earnings profile, rather than a clear durable compounder. Its thesis is in a watch state: the recent signal improved from mixed to mildly favorable, but financial performance remains weak versus its industry cohort.
IOR is valued at a premium of about 53% to peers, despite weak recent results and elevated risk. The evidence suggests that only weak execution quality is reflected in the fragility assessment, not a broader combination of expensive valuation and turbulence.
Near term, earnings face pressure: net income fell from $1.0 million in 2026-Q1 to $0.7 million in 2026-Q2, while diluted earnings per share fell from $0.25 to $0.17. Operating expenses stayed steady at $97,000 per quarter, but lower interest income from related parties contributed to the decline; the evidence gives limited support for a firmer multi-year trajectory.
The key swing factor is whether interest income and earnings stabilize while management maintains expense discipline. Near term, the sector backdrop could weaken if the Federal Reserve begins cutting rates or if bellwethers RKT, PFSI, and UWMC miss expectations or guide lower; continued strong results from those companies could support sector momentum.
Over the next one to three years, IOR’s thesis hinges on stabilizing earnings and related-party interest income, while its premium valuation leaves little support in the current weak results. Evidence is limited, so the multi-year view remains watchful. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.